A detailed history of Virtu Financial LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 13,526 shares of APLS stock, worth $371,829. This represents 0.02% of its overall portfolio holdings.

Number of Shares
13,526
Holding current value
$371,829
% of portfolio
0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

BUY
$28.84 - $41.15 $390,089 - $556,594
13,526 New
13,526 $390,000
Q3 2023

Nov 14, 2023

BUY
$23.65 - $89.22 $549,507 - $2.07 Million
23,235 New
23,235 $884,000
Q3 2021

Nov 12, 2021

SELL
$31.4 - $69.84 $136,244 - $303,035
-4,339 Closed
0 $0
Q2 2021

Sep 17, 2021

SELL
$40.9 - $64.9 $473,581 - $751,477
-11,579 Reduced 72.74%
4,339 $274,000
Q3 2018

Nov 13, 2018

BUY
$16.57 - $21.03 $263,761 - $334,755
15,918 New
15,918 $283,000

Others Institutions Holding APLS

About Apellis Pharmaceuticals, Inc.


  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.02B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.